论文部分内容阅读
目的观察诺舒阻抗控制系统子宫内膜去除术治疗异常子宫出血合并严重内科疾病的临床效果。方法对29例异常子宫出合并严重内科疾病患者,采用诺舒阻抗控制系统子宫内膜去除术进行治疗,分析术中出血情况及术后1、3、6、12个月的疗效及并发症。结果 29例患者均顺利通过了麻醉及手术,内科疾病无加重,术后连续追踪1、3、6、12个月,29例患者均显效,术后1、3、6、12个月有效率分别为:100%、100%、100%、100%,闭经率65.5%、69.0%、69.0%、72.4%,治疗满意率93.1%,术中及术后均未发生严重并发症。结论对于保守治疗无效且不能耐受手术的合并严重内科疾病的异常子宫出血,诺舒阻抗控制系统子宫内膜去除术可做为首选的治疗方式。
Objective To observe the clinical effect of Nosocomial resistance control system endometrial ablation in the treatment of abnormal uterine bleeding combined with severe medical diseases. Methods Twenty - nine patients with abnormal uterus and severe internal diseases were treated with Novus impedance control endometrial ablation. The intraoperative bleeding and the efficacy and complications at 1, 3, 6 and 12 months after operation were analyzed. Results All of the 29 patients passed anesthesia and operation successfully. There was no aggravation of internal diseases. The patients were followed up for 1, 3, 6, and 12 months after operation. All of the 29 patients were effective, and 1,3,6 and 12 months after operation The rates of amenorrhea were 65.5%, 69.0%, 69.0% and 72.4%, respectively. The treatment satisfaction rate was 93.1%. No serious complications occurred during and after operation. CONCLUSIONS: Nauseau resistance-controlled endometrial ablation may be the preferred treatment for patients with abnormal uterine bleeding that is refractory to conservative treatment and can not tolerate surgery with severe medical conditions.